课题基金 / 基金详情

GROWTH & DIFFERENTIATION OF IMMATURE T CELLS & THYMOMAS

GROWTH & DIFFERENTIATION OF IMMATURE T CELLS & THYMOMAS
生长
批准号:
3199712
负责人:
KENNETH L ROCK
金额:
$22.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-08-01 至 1997-07-31

项目摘要

项目成果

KENNETH L ROCK的其他基金

相似基金

相关文献

中文摘要
翻译
该项目有两个潜在的相关目标。 第一个目标是 以确定细胞和分子之间的相互作用, 未成熟的胸腺细胞发育。 第二个目标是调查 这些相互作用如何参与发展 恶性胸腺肿瘤 这些研究将提供深入了解 免疫系统的发展以及这个过程 在恶性肿瘤中变得紊乱。 实验设计将 开发一个独特的体外模型来定义细胞之间的相互作用 信号刺激未成熟的肿瘤增殖, 区分。 这些研究将扩展到分析 肿瘤在体内的生长需求。 其他实验将 扩展这些研究,以分析正常的发展, 胸腺细胞
英文摘要
This project has two potentially related goals. The first goal is to identify the cellular and molecular interactions that stimulate immature thymocytes to develop. The second goal is to investigate how these interactions may be involved in the development of malignant thymic tumors. These studies will provide insight into the development of the immune system and into how this process becomes disordered in malignancy. The experimental design will develop a unique in vitro model to define what cell interactions and signals stimulate immature tumors to proliferate and differentiate. These studies will then be extended to analyze the growth requirements of tumors in vivo. Other experiments will extend these studies to analyze the development of normal thymocytes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel histone-binding C-type lectin receptors and their role in sterile inflammation and tissue injury
Role of IRF2 in cancer immune evasion and immunotherapy
Role of IRF2 in cancer immune evasion and immunotherapy
Role of IRF2 in cancer immune evasion and immunotherapy
海外基金